Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Tempest Therapeutics Inc.

    NASDAQ: TPST · Real-Time Price · USD
    7.08
    -0.07 (-0.98%)
    At close: Jun 26, 2025, 3:59 PM

    Tempest Therapeutics Statistics

    Share Statistics

    Tempest Therapeutics has 4.09M shares outstanding. The number of shares has increased by -4.76% in one year.

    Shares Outstanding

    n/a
    		 4.09M

    Shares Change (YoY)

    n/a
    		 -4.76%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 26.28%

    Shares Floating

    n/a
    		 3.74M

    Failed to Deliver (FTD) Shares

    n/a
    		 370

    FTD / Avg. Volume

    n/a
    		 0.3%

    Short Selling Information

    The latest short interest is 111.17K, so 3.02% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 111.17K

    Short % of Shares Out

    n/a
    		 3.02%

    Short % of Float

    n/a
    		 3.02%

    Short Ratio (days to cover)

    n/a
    		 2.83

    Valuation Ratios

    The PE ratio is -7.24 and the forward PE ratio is -0.69. Tempest Therapeutics's PEG ratio is 0.34.

    PE Ratio

    n/a
    		 -7.24

    Forward PE

    n/a
    		 -0.69

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 15.83

    P/FCF Ratio

    n/a
    		 -9.05

    PEG Ratio

    n/a
    		 0.34
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Tempest Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.8.

    Current Ratio

    n/a
    		 2.21

    Quick Ratio

    n/a
    		 2.21

    Debt / Equity

    n/a
    		 0.8

    Debt / EBITDA

    n/a
    		 -0.38

    Debt / FCF

    n/a
    		 -0.46

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,743,458.33

    Employee Count

    n/a
    		 24

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 226.27% in the last 52 weeks. The beta is -2.33, so Tempest Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -2.33

    52-Week Price Change

    n/a
    		 226.27%

    50-Day Moving Average

    n/a
    		 7.03

    200-Day Moving Average

    n/a
    		 11.08

    Relative Strength Index (RSI)

    n/a
    		 49.91

    Average Volume (20 Days)

    n/a
    		 122,732

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -42.03M

    Net Income

    n/a
    		 -41.84M

    EBITDA

    n/a
    		 -40.14M

    EBIT

    n/a
    		 -40.53M

    Earnings Per Share (EPS)

    n/a
    		 -1.5
    Full Income Statement

    Balance Sheet

    The company has 30.27M in cash and 15.37M in debt, giving a net cash position of 14.9M.

    Cash & Cash Equivalents

    n/a
    		 30.27M

    Total Debt

    n/a
    		 15.37M

    Net Cash

    n/a
    		 14.9M

    Retained Earnings

    n/a
    		 -207.11M

    Total Assets

    n/a
    		 32.16M

    Working Capital

    n/a
    		 9.26M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -33.03M and capital expenditures -435K, giving a free cash flow of -33.46M.

    Operating Cash Flow

    n/a
    		 -33.03M

    Capital Expenditures

    n/a
    		 -435K

    Free Cash Flow

    n/a
    		 -33.46M

    FCF Per Share

    n/a
    		 -1.2
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TPST does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TPST is $16, which is 126% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $16

    Price Target Difference

    n/a
    		 126%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 9, 2025. It was a backward split with a ratio of 1:13.

    Last Split Date

    n/a
    		 Apr 9, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:13

    Scores

    Altman Z-Score

    n/a
    		 -12.86

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist